Evidence map›Paper›PMID 35611657›Full record

ArticlemSphere2022

Immunization of Rabbits with a Quadrivalent

Elizabeth A Odundo, Hailey P Weerts, Lillian Musila, Lilian Ogonda, Anita M Dreyer, Joerg Schneider, Paula Carranza, Robert W Kaminski

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Human vaccines & immunotherapeutics · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2024
    Review
  6. Age-dependent acquisition of IgG antibodies toFrontiers in immunology · 2024
    Article
  7. Article
  8. A NovelmSphere · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Elizabeth A OdundoMicrobiology Hub Kericho, KEMRI-USAMRD-A/Kenya, Kericho, Kenya.
Hailey P WeertsDepartment of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Lillian MusilaMicrobiology Hub Kericho, KEMRI-USAMRD-A/Kenya, Kericho, Kenya.ORCID 0000-0003-1418-6523
Lilian OgondaDepartment of Biomedical Science and Technology, Maseno Universitygrid.442486.8, Maseno, Kenya.
Anita M DreyerLimmaTech Biologics AG, Schlieren, Switzerland.
Joerg SchneiderLimmaTech Biologics AG, Schlieren, Switzerland.
Paula CarranzaLimmaTech Biologics AG, Schlieren, Switzerland.
Robert W KaminskiDepartment of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.ORCID 0000-0002-4015-5694
Spital Limmattal · CHKenya Medical Research Institute · KEWalter Reed Army Institute of Research · USMaseno University · KE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Diarrheal diseases are a leading cause of global morbidity and mortality, disproportionately affecting children in resource-limited settings. Although improvements in hygiene and access to clean water are helpful, vaccines are considered essential due to the low infectious dose of

Indexed as

Dysentery, BacillaryShigellaShigella VaccinesAnimalsAntibodies, BacterialAntigens, BacterialDiarrheaKenyaRabbitsShigella sonneiVaccinationVaccines, CombinedAntibodies, BacterialAntigens, BacterialShigella VaccinesVaccines, Combinedantibodybioconjugate vaccinefunctionalpreclinicalShigella

Identifiers

PMID35611657
PMCPMC9241535
OpenAlexW4281565911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.